+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID06588413

Study Comparing Low Doses of Olanzapine 2.5 mg vs 5 mg with Standard Medications to Prevent Nausea and Vomiting in Patients Receiving High-Dose Melphalan Chemotherapy for Multiple Myeloma

Led by Augusta University · Updated on 2024-11-22

172

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying patients with multiple myeloma who receive high-dose melphalan chemotherapy before autologous stem cell transplantation. This trial aims to compare two lower doses of olanzapine 2.5 mg and 5 mg, given with three standard anti-nausea medications, to find which dose best prevents nausea and vomiting while causing the least sleepiness side effect. The study is randomized and double-blinded, focusing on chemotherapy-induced nausea, vomiting, and sedation outcomes. Participants will be randomly assigned to receive either 2.5 mg or 5 mg of olanzapine on the day they receive high-dose melphalan and for three days afterward. Both groups will continue to receive the standard three medications routinely used to prevent nausea and vomiting. The study compares these two olanzapine doses as part of quadruplet antiemetic prophylaxis. During the study, participants will be monitored from the day of chemotherapy through five days after for nausea, vomiting, sedation, and the need for additional antiemetic medications. Researchers will use measures such as complete response to nauseavomiting, protection from nausea, number of vomiting episodes, and sedation levels. The trial includes assessments of these effects to determine the best olanzapine dose. The entire participation period covers the acute and delayed phases of chemotherapy side effects.

CONDITIONS

Brief Title

Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan

Research Team

A

Amber Clemmons, PharmD, BCOP, FHOPA

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here